 | • レポートコード：QFJ1-4411 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、高分子注射薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈注射、筋肉注射、皮下注射）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・高分子注射薬の市場動向 ・企業の競争状況、市場シェア ・高分子注射薬の種類別市場規模と予測2016-2027（静脈注射、筋肉注射、皮下注射） ・高分子注射薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・高分子注射薬の北米市場規模2016-2027（アメリカ、カナダ） ・高分子注射薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・高分子注射薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・高分子注射薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・高分子注射薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biogen、AstraZeneca、Roche、Sun Pharmaceutical、Medtronic、Novartis、Baxter、Amgen、Pfizer、Johnson & Johnson） ・結論 |
Large molecules (biologics), also called biopharmaceuticals, are a type of drugs. These are based on proteins which have a therapeutic effect.
Market Analysis and Insights: Global Large Molecule Injectable Drugs Market
The global Large Molecule Injectable Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Large Molecule Injectable Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Large Molecule Injectable Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Large Molecule Injectable Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Large Molecule Injectable Drugs market.
Global Large Molecule Injectable Drugs Scope and Market Size
Large Molecule Injectable Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Large Molecule Injectable Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Intravenous Injection
Muscle Injection
Subcutaneous Injection
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Biogen
AstraZeneca
Roche
Sun Pharmaceutical
Medtronic
Novartis
Baxter
Amgen
Pfizer
Johnson & Johnson
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Large Molecule Injectable Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous Injection
1.2.3 Muscle Injection
1.2.4 Subcutaneous Injection
1.3 Market by Application
1.3.1 Global Large Molecule Injectable Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Large Molecule Injectable Drugs Market Perspective (2016-2027)
2.2 Large Molecule Injectable Drugs Growth Trends by Regions
2.2.1 Large Molecule Injectable Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Large Molecule Injectable Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Large Molecule Injectable Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Large Molecule Injectable Drugs Industry Dynamic
2.3.1 Large Molecule Injectable Drugs Market Trends
2.3.2 Large Molecule Injectable Drugs Market Drivers
2.3.3 Large Molecule Injectable Drugs Market Challenges
2.3.4 Large Molecule Injectable Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Large Molecule Injectable Drugs Players by Revenue
3.1.1 Global Top Large Molecule Injectable Drugs Players by Revenue (2016-2021)
3.1.2 Global Large Molecule Injectable Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Large Molecule Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Large Molecule Injectable Drugs Revenue
3.4 Global Large Molecule Injectable Drugs Market Concentration Ratio
3.4.1 Global Large Molecule Injectable Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Large Molecule Injectable Drugs Revenue in 2020
3.5 Large Molecule Injectable Drugs Key Players Head office and Area Served
3.6 Key Players Large Molecule Injectable Drugs Product Solution and Service
3.7 Date of Enter into Large Molecule Injectable Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Large Molecule Injectable Drugs Breakdown Data by Type
4.1 Global Large Molecule Injectable Drugs Historic Market Size by Type (2016-2021)
4.2 Global Large Molecule Injectable Drugs Forecasted Market Size by Type (2022-2027)
5 Large Molecule Injectable Drugs Breakdown Data by Application
5.1 Global Large Molecule Injectable Drugs Historic Market Size by Application (2016-2021)
5.2 Global Large Molecule Injectable Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Large Molecule Injectable Drugs Market Size (2016-2027)
6.2 North America Large Molecule Injectable Drugs Market Size by Type
6.2.1 North America Large Molecule Injectable Drugs Market Size by Type (2016-2021)
6.2.2 North America Large Molecule Injectable Drugs Market Size by Type (2022-2027)
6.2.3 North America Large Molecule Injectable Drugs Market Size by Type (2016-2027)
6.3 North America Large Molecule Injectable Drugs Market Size by Application
6.3.1 North America Large Molecule Injectable Drugs Market Size by Application (2016-2021)
6.3.2 North America Large Molecule Injectable Drugs Market Size by Application (2022-2027)
6.3.3 North America Large Molecule Injectable Drugs Market Size by Application (2016-2027)
6.4 North America Large Molecule Injectable Drugs Market Size by Country
6.4.1 North America Large Molecule Injectable Drugs Market Size by Country (2016-2021)
6.4.2 North America Large Molecule Injectable Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Large Molecule Injectable Drugs Market Size (2016-2027)
7.2 Europe Large Molecule Injectable Drugs Market Size by Type
7.2.1 Europe Large Molecule Injectable Drugs Market Size by Type (2016-2021)
7.2.2 Europe Large Molecule Injectable Drugs Market Size by Type (2022-2027)
7.2.3 Europe Large Molecule Injectable Drugs Market Size by Type (2016-2027)
7.3 Europe Large Molecule Injectable Drugs Market Size by Application
7.3.1 Europe Large Molecule Injectable Drugs Market Size by Application (2016-2021)
7.3.2 Europe Large Molecule Injectable Drugs Market Size by Application (2022-2027)
7.3.3 Europe Large Molecule Injectable Drugs Market Size by Application (2016-2027)
7.4 Europe Large Molecule Injectable Drugs Market Size by Country
7.4.1 Europe Large Molecule Injectable Drugs Market Size by Country (2016-2021)
7.4.2 Europe Large Molecule Injectable Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Large Molecule Injectable Drugs Market Size (2016-2027)
8.2 Asia-Pacific Large Molecule Injectable Drugs Market Size by Type
8.2.1 Asia-Pacific Large Molecule Injectable Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Large Molecule Injectable Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Large Molecule Injectable Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Large Molecule Injectable Drugs Market Size by Application
8.3.1 Asia-Pacific Large Molecule Injectable Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Large Molecule Injectable Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Large Molecule Injectable Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Large Molecule Injectable Drugs Market Size by Region
8.4.1 Asia-Pacific Large Molecule Injectable Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Large Molecule Injectable Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Large Molecule Injectable Drugs Market Size (2016-2027)
9.2 Latin America Large Molecule Injectable Drugs Market Size by Type
9.2.1 Latin America Large Molecule Injectable Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Large Molecule Injectable Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Large Molecule Injectable Drugs Market Size by Type (2016-2027)
9.3 Latin America Large Molecule Injectable Drugs Market Size by Application
9.3.1 Latin America Large Molecule Injectable Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Large Molecule Injectable Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Large Molecule Injectable Drugs Market Size by Application (2016-2027)
9.4 Latin America Large Molecule Injectable Drugs Market Size by Country
9.4.1 Latin America Large Molecule Injectable Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Large Molecule Injectable Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Large Molecule Injectable Drugs Market Size (2016-2027)
10.2 Middle East & Africa Large Molecule Injectable Drugs Market Size by Type
10.2.1 Middle East & Africa Large Molecule Injectable Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Large Molecule Injectable Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Large Molecule Injectable Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Large Molecule Injectable Drugs Market Size by Application
10.3.1 Middle East & Africa Large Molecule Injectable Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Large Molecule Injectable Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Large Molecule Injectable Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Large Molecule Injectable Drugs Market Size by Country
10.4.1 Middle East & Africa Large Molecule Injectable Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Large Molecule Injectable Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Large Molecule Injectable Drugs Introduction
11.1.4 Biogen Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.1.5 Biogen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Large Molecule Injectable Drugs Introduction
11.2.4 AstraZeneca Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Large Molecule Injectable Drugs Introduction
11.3.4 Roche Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Large Molecule Injectable Drugs Introduction
11.4.4 Sun Pharmaceutical Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Large Molecule Injectable Drugs Introduction
11.5.4 Medtronic Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.5.5 Medtronic Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Large Molecule Injectable Drugs Introduction
11.6.4 Novartis Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Baxter
11.7.1 Baxter Company Details
11.7.2 Baxter Business Overview
11.7.3 Baxter Large Molecule Injectable Drugs Introduction
11.7.4 Baxter Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.7.5 Baxter Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Large Molecule Injectable Drugs Introduction
11.8.4 Amgen Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.8.5 Amgen Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Large Molecule Injectable Drugs Introduction
11.9.4 Pfizer Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Large Molecule Injectable Drugs Introduction
11.10.4 Johnson & Johnson Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Large Molecule Injectable Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intravenous Injection
Table 3. Key Players of Muscle Injection
Table 4. Key Players of Subcutaneous Injection
Table 5. Global Large Molecule Injectable Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Large Molecule Injectable Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Large Molecule Injectable Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Large Molecule Injectable Drugs Market Share by Regions (2016-2021)
Table 9. Global Large Molecule Injectable Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Large Molecule Injectable Drugs Market Share by Regions (2022-2027)
Table 11. Large Molecule Injectable Drugs Market Trends
Table 12. Large Molecule Injectable Drugs Market Drivers
Table 13. Large Molecule Injectable Drugs Market Challenges
Table 14. Large Molecule Injectable Drugs Market Restraints
Table 15. Global Large Molecule Injectable Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Large Molecule Injectable Drugs Market Share by Players (2016-2021)
Table 17. Global Top Large Molecule Injectable Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Large Molecule Injectable Drugs as of 2020)
Table 18. Ranking of Global Top Large Molecule Injectable Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Large Molecule Injectable Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Large Molecule Injectable Drugs Product Solution and Service
Table 22. Date of Enter into Large Molecule Injectable Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Large Molecule Injectable Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Large Molecule Injectable Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Large Molecule Injectable Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Large Molecule Injectable Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Large Molecule Injectable Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Large Molecule Injectable Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Large Molecule Injectable Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Large Molecule Injectable Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Large Molecule Injectable Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Large Molecule Injectable Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Large Molecule Injectable Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Large Molecule Injectable Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Large Molecule Injectable Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Large Molecule Injectable Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Large Molecule Injectable Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Large Molecule Injectable Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Large Molecule Injectable Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Large Molecule Injectable Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Large Molecule Injectable Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Large Molecule Injectable Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Large Molecule Injectable Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Large Molecule Injectable Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Large Molecule Injectable Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Large Molecule Injectable Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Large Molecule Injectable Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Large Molecule Injectable Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Large Molecule Injectable Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Large Molecule Injectable Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Large Molecule Injectable Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Large Molecule Injectable Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Large Molecule Injectable Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Large Molecule Injectable Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Large Molecule Injectable Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Large Molecule Injectable Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Large Molecule Injectable Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Large Molecule Injectable Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Large Molecule Injectable Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Large Molecule Injectable Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Biogen Company Details
Table 63. Biogen Business Overview
Table 64. Biogen Large Molecule Injectable Drugs Product
Table 65. Biogen Revenue in Large Molecule Injectable Drugs Business (2016-2021) & (US$ Million)
Table 66. Biogen Recent Development
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Large Molecule Injectable Drugs Product
Table 70. AstraZeneca Revenue in Large Molecule Injectable Drugs Business (2016-2021) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Roche Company Details
Table 73. Roche Business Overview
Table 74. Roche Large Molecule Injectable Drugs Product
Table 75. Roche Revenue in Large Molecule Injectable Drugs Business (2016-2021) & (US$ Million)
Table 76. Roche Recent Development
Table 77. Sun Pharmaceutical Company Details
Table 78. Sun Pharmaceutical Business Overview
Table 79. Sun Pharmaceutical Large Molecule Injectable Drugs Product
Table 80. Sun Pharmaceutical Revenue in Large Molecule Injectable Drugs Business (2016-2021) & (US$ Million)
Table 81. Sun Pharmaceutical Recent Development
Table 82. Medtronic Company Details
Table 83. Medtronic Business Overview
Table 84. Medtronic Large Molecule Injectable Drugs Product
Table 85. Medtronic Revenue in Large Molecule Injectable Drugs Business (2016-2021) & (US$ Million)
Table 86. Medtronic Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Large Molecule Injectable Drugs Product
Table 90. Novartis Revenue in Large Molecule Injectable Drugs Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Baxter Company Details
Table 93. Baxter Business Overview
Table 94. Baxter Large Molecule Injectable Drugs Product
Table 95. Baxter Revenue in Large Molecule Injectable Drugs Business (2016-2021) & (US$ Million)
Table 96. Baxter Recent Development
Table 97. Amgen Company Details
Table 98. Amgen Business Overview
Table 99. Amgen Revenue in Large Molecule Injectable Drugs Business (2016-2021) & (US$ Million)
Table 100. Amgen Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Large Molecule Injectable Drugs Product
Table 104. Pfizer Revenue in Large Molecule Injectable Drugs Business (2016-2021) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Johnson & Johnson Company Details
Table 107. Johnson & Johnson Business Overview
Table 108. Johnson & Johnson Large Molecule Injectable Drugs Product
Table 109. Johnson & Johnson Revenue in Large Molecule Injectable Drugs Business (2016-2021) & (US$ Million)
Table 110. Johnson & Johnson Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Large Molecule Injectable Drugs Market Share by Type: 2020 VS 2027
Figure 2. Intravenous Injection Features
Figure 3. Muscle Injection Features
Figure 4. Subcutaneous Injection Features
Figure 5. Global Large Molecule Injectable Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Large Molecule Injectable Drugs Report Years Considered
Figure 10. Global Large Molecule Injectable Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Large Molecule Injectable Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Large Molecule Injectable Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Large Molecule Injectable Drugs Market Share by Regions (2022-2027)
Figure 14. Global Large Molecule Injectable Drugs Market Share by Players in 2020
Figure 15. Global Top Large Molecule Injectable Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Large Molecule Injectable Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Large Molecule Injectable Drugs Revenue in 2020
Figure 17. Global Large Molecule Injectable Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Large Molecule Injectable Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Large Molecule Injectable Drugs Market Share by Type (2016-2027)
Figure 21. North America Large Molecule Injectable Drugs Market Share by Application (2016-2027)
Figure 22. North America Large Molecule Injectable Drugs Market Share by Country (2016-2027)
Figure 23. United States Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Large Molecule Injectable Drugs Market Share by Type (2016-2027)
Figure 27. Europe Large Molecule Injectable Drugs Market Share by Application (2016-2027)
Figure 28. Europe Large Molecule Injectable Drugs Market Share by Country (2016-2027)
Figure 29. Germany Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Large Molecule Injectable Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Large Molecule Injectable Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Large Molecule Injectable Drugs Market Share by Region (2016-2027)
Figure 39. China Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Large Molecule Injectable Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Large Molecule Injectable Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Large Molecule Injectable Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Large Molecule Injectable Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Large Molecule Injectable Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Large Molecule Injectable Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Large Molecule Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Biogen Revenue Growth Rate in Large Molecule Injectable Drugs Business (2016-2021)
Figure 59. AstraZeneca Revenue Growth Rate in Large Molecule Injectable Drugs Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Large Molecule Injectable Drugs Business (2016-2021)
Figure 61. Sun Pharmaceutical Revenue Growth Rate in Large Molecule Injectable Drugs Business (2016-2021)
Figure 62. Medtronic Revenue Growth Rate in Large Molecule Injectable Drugs Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Large Molecule Injectable Drugs Business (2016-2021)
Figure 64. Baxter Revenue Growth Rate in Large Molecule Injectable Drugs Business (2016-2021)
Figure 65. Amgen Revenue Growth Rate in Large Molecule Injectable Drugs Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Large Molecule Injectable Drugs Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Large Molecule Injectable Drugs Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の注射式駆虫薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Injectable Anthelmintic Drugs Market The global Injectable Anthelmintic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…- 世界の高分子生物分析市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Large Molecule Bioanalytical Market The global Large Molecule Bioanalytical market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
- 世界のジェネリック腫瘍薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Generic Oncology Drugs Market The global Generic Oncology Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…
- 世界のモノクローナル抗体滅菌注射薬産業調査2019-2025 Monoclonal antibodies are produced through cell division from a single ancestral or parent cell.In 2018, the global Monoclonal Antibodies Sterile Injectable Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been…
- 世界のモノクローナル抗体滅菌注射薬産業調査2019-2025 Monoclonal antibodies are produced through cell division from a single ancestral or parent cell.In 2018, the global Monoclonal Antibodies Sterile Injectable Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been…